In 2020, the global outbreak of CovID-19 caused a large amount of investment and research activities to develop vaccines. Many organizations are using published genomes to develop possible anti-SARS-CoV-2 vaccines. An mRNA vaccine against SARS-CoV-2, the causative virus, may show its advantages in a shorter time and become a valuable tool for disease prevention.
Relying on advanced mRNA technology and rich experience in the development of mRNA vaccines, BOC RNA can design and synthesize mRNA sequences from DNA templates and produce laboratory-scale or GMP-level mRNA vaccines to match your application from research to clinical trials.
Since the emergence of the new coronavirus (COVID-19), BOC RNA has stepped up our efforts and is committed to research and development of vaccines and treatments to contain the virus. We will continue to maintain industry cooperation to achieve the greatest chance of success.
More Information
Other COVID-19 Related Services
Liposomes Drug Delivery Services For COVID-19
Custom Oligo Synthesis Services For COVID-19 Research
COVID-19 Resources & News
| ||
Will the mRNA vaccine become the “savior” of COVID-19？ Cell Immunity: SARS-CoV-2 vaccines status bioRxiv.: Scientists Find siRNA drugs that may inhibit SARS-CoV-2 | ||
Global Supplier of High-Quality RNA / DNA Products & Services.
